[Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management]
MMW Fortschr Med
.
2021 Jan;163(1):48-51.
doi: 10.1007/s15006-021-9530-6.
[Article in German]
Authors
Margitta Worm
1
,
Johannes Ring
2
,
Ludger Klimek
3
,
Thilo Jakob
4
,
Lars Lange
5
,
Regina Treudler
6
,
Kirsten Beyer
7
,
Thomas Werfel
8
,
Tilo Biedermann
2
,
Andreas Bircher
9
,
Matthias Fischer
10
,
Thomas Fuchs
11
,
Axel R Heller
12
,
Florian Hoffmann
2
,
Isidor Huttegger
13
,
Matthias Volkmar Kopp
14
,
Claudia Kugler
2
,
Marek Lommatzsch
15
,
Oliver Pfaar
16
,
Ernst Rietschel
17
,
Franziska Rueff
2
,
Sabine Schnadt
18
,
Roland Seifert
8
,
Britta Stöcker
5
,
Christian Vogelberg
19
,
Helmut Sitter
16
,
Uwe Gieler
4
,
Knut Brockow
2
Affiliations
1
Allergie-Centrum-Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
[email protected]
.
2
, München, Germany.
3
, Wiesbaden, Germany.
4
, Gießen, Germany.
5
, Bonn, Germany.
6
, Leipzig, Germany.
7
, Berlin, Germany.
8
, Hannover, Germany.
9
, Basel, Schweiz.
10
, Göppingen, Germany.
11
, Göttingen, Germany.
12
, Augsburg, Germany.
13
, Salzburg, Österreich.
14
, Lübeck, Germany.
15
, Rostock, Germany.
16
, Marburg, Germany.
17
, Köln, Germany.
18
, Mönchengladbach, Germany.
19
, Dresden, Germany.
PMID:
33464512
PMCID:
PMC7814269
DOI:
10.1007/s15006-021-9530-6
No abstract available
Publication types
Review
MeSH terms
Anaphylaxis* / chemically induced
Anaphylaxis* / prevention & control
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects*
Humans
Vaccination / adverse effects*
Substances
COVID-19 Vaccines